SK Biopharmaceuticals Co., Ltd. (KRX:326030)
105,600
+500 (0.48%)
Mar 12, 2025, 9:00 AM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.26 trillion as of March 12, 2025. Its market cap has increased by 23.83% in one year.
Market Cap
8.26T
Enterprise Value
8.20T
Revenue
511.33B
Ranking
n/a
PE Ratio
143.98
Stock Price
105,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.26T, a decrease of -16.93%. That is a compound annual growth rate of -3.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 11, 2025 | 8,230.72B | -5.40% |
Dec 30, 2024 | 8,700.60B | 10.66% |
Dec 28, 2023 | 7,862.65B | 39.25% |
Dec 29, 2022 | 5,646.39B | -25.82% |
Dec 30, 2021 | 7,612.05B | -42.49% |
Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition